An inhibitory effect of metformin on the phosphorylation of mTOR, which has been reported in cancer cells including those of pancreatic cancer [36], [37], was observed in CD133+ pancreatic cancer cells in this study. The gene discussed is PROM1; the disease is pancreatic neoplasm.